Vanda patents found valid and infringed in Fanapt® ANDA litigation
Vanda announced Judge Gregory M. Sleet of the U.S. District Court for the District of Delaware ruled that Roxane Laboratories infringed U.S. Patent Nos. RE39,198 and 8,586,610 by submitting to the FDA an ANDA seeking permission to market a generic version of Fanapt® before the patent expiration. August 25, 2016